Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs), while having changed the treatment of multiple cancers, come with novel immune-related adverse events (irAEs) resembling autoimmune diseases. The registration data suggest that at least some irAEs have a prognostic nature regarding the efficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuusisalo, Saara, Koivunen, Jussi P., Iivanainen, Sanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103509/
https://www.ncbi.nlm.nih.gov/pubmed/35565405
http://dx.doi.org/10.3390/cancers14092276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103509/
https://www.ncbi.nlm.nih.gov/pubmed/35565405
http://dx.doi.org/10.3390/cancers14092276

Ejemplares similares